MINGHETTI, PAOLA
MINGHETTI, PAOLA
Dipartimento di Scienze Farmaceutiche
Regulatory Challenges and Classification of Substance-Based Medical Devices under Regulation (EU) 2017/745
2026 U.M. Musazzi, S. Azari, P. Minghetti
Relevant factors to guarantee quality of oligonucleotide-based products
2026 S. Azari, S. Manellari, G. Anderluzzi, P. Minghetti, U.M. Musazzi
Messenger RNA (mRNA) based therapeutics in transforming cardiovascular care: Progress, regulatory challenges and future perspectives
2025 M. Khan, U.M. Musazzi, S. Manellari, N. Mouawad, G. Damiano, R. Rinaldi, A. Raucci, S. Costantino, F. Paneni, P. Minghetti, G. Pompilio, M.C. Vinci
Back to gene therapy: bringing the EU regulation into the future
2025 U.M. Musazzi, P. Rocco, S. Manellari, S. Azari, G. Pompilio, P. Minghetti
Regulatory aspects of 3D printing systems in healthcare
2025 P. Minghetti, U.M. Musazzi, P. Rocco
Bergamot waste derived lipid nanosystems as novel excipients for (trans)dermal drug delivery
2025 P. Volonté, C. Ricci, S. Arnoldi, G. Roda, E. DEL FAVERO, F. Puoci, P. Minghetti, S. Franze', F. Cilurzo
Equivalence assessment of creams with quali-quantitative differences in light of the EMA and FDA regulatory framework
2024 P. Volonte', U.M. Musazzi, L. Arnaboldi, M.A. Ortenzi, A. Casiraghi, F. Cilurzo, P. Minghetti
β-galactosidase orodispersible dosage forms for the treatment of lactose intolerance
2024 U.M. Musazzi, C. Meazzini, G. Anderluzzi, G. Frigerio, F. Selmin, P. Minghetti, F. Cilurzo
Updating ‘Data on the determination of human epidermis integrity in skin permeation experiments by electrical resistance’ with Data on pig ear skin
2024 P. Volonte', U.M. Musazzi, C. Gennari, A. Casiraghi, F. Cilurzo, P. Minghetti
Pediatric oral extemporaneous preparations and practices: International Pharmaceutical Federation (FIP) global study
2024 H.M. Fadda, H. Weiler, M. Carvalho, Y.Z. Lee, H. Dassouki, R. Abublan, S. Iurian, A. Hamid, G. Şeremet, Z. Li, C. Tuleu, P. Minghetti, G.M. Pauletti
Patient-managed digital medical devices: Do we need further regulation?
2024 P. Minghetti, U.M. Musazzi, S. Manellari, V. Pagella, P. Rocco
Digital Technologies Applied to Control the One-Step Process of Cannabis Olive Oil Preparations
2023 P. Bongiorno, A. Lopalco, A. Casiraghi, P.A. Spennacchio, A. Pitruzzella, A. Assunta Lopedota, P. Minghetti, N. Denora
Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System
2023 S. Crisafulli, P. Maria Cutroneo, N. Luxi, A. Fontana, C. Ferrajolo, P. Marchione, L. Sottosanti, G. Zanoni, U. Moretti, S. Franze', P. Minghetti, G. Trifirò
Nature of the Interaction of Alpha-D-Mannose and Escherichia coli Bacteria, and Implications for its Regulatory Classification. A Delphi Panel European Consensus Based on Chemistry and Legal Evidence
2023 F. Scaglione, P. Minghetti, F. Ambrosio, B. Ernst, V. Ficarra, M. Gobbi, K. Naber, H. Schellekens
Marketing authorisations for unmet medical needs: A critical appraisal of regulatory pathways in the European Union
2023 S. Manellari, U.M. Musazzi, P. Rocco, P. Minghetti
Cases of drug repositioning in children's orphan drugs: Licenced drugs versus unlicenced magistral preparations
2023 D. Zanon, U.M. Musazzi, M. Cirino, G. Bennati, A. Casiraghi, N. Maximova, E. Barbi, P. Minghetti
Feeding Next-Generation Nanomedicines to Europe: Regulatory and Quality Challenges
2023 U.M. Musazzi, S. Franze, F. Condorelli, P. Minghetti, P. Caliceti
Drug repositioning: is it always worth?
2022 U.M. Musazzi, D. Zanon, P. Minghetti
Medicinal products, medical devices, or accessories of medical devices: How to qualify gases for spirometry?
2022 S. Manellari, M.G. Leone, A. Casiraghi, C.G.M. Gennari, P. Minghetti
Drug repositioning: when compounding is worth for children treating
2022 U.M. Musazzi, D. Zanon, M. Cirino, P. Minghetti